Search results
Novavax Stock More Than Doubles On Deal With Sanofi To Co-commercialize Covid-19 Vaccine
RTT News· 13 hours agoNovavax also announced a co-exclusive licensing agreement with Sanofi to co-commercialize Covid-19 vaccine and develop ...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 17 hours agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
Novavax Sheds Going Concern Warning as NVAX Stock Pops on Sanofi Licensing Deal
InvestorPlace· 10 hours agoCovid-19 vaccine. The agreement will also provide Sanofi with a sole license to the vaccine for use...
Biotech Rockets 125% On Sanofi Covid Vaccine Agreement
Investor's Business Daily· 11 hours agoNovavax shares shot more than 125% higher Friday on news of a Covid-19 vaccine licensing agreement...
French, US drug firms team up for Covid-flu shot
Medical Xpress· 14 hours agoUnder a licensing deal worth up to $1.2 billion, the companies will co-commercialize Novavax's COVID-19 vaccine worldwide ...
France's Sanofi in COVID-19 vaccine deal with Novavax - statement
Reuters via Yahoo Finance· 21 hours ago"We're excited by the prospect of combining Novavax's adjuvanted COVID-19 vaccine that has shown high efficacy and ...
French, US drug firms team up for Covid-flu shot
Digital Journal· 9 hours agoUnder a licensing deal worth up to $1.2 billion, the companies will co-commercialise Novavax’s Covid-19 vaccine worldwide ...
Novavax’s 99% Surge Gives ‘Rib-Crunching’ Squeeze to Shorts
Bloomberg via Yahoo Finance· 6 hours ago(Bloomberg) -- Novavax Inc.’s record one-day gain is forcing some short sellers betting against the...
Novavax stock soars 120% as Sanofi deal 'kicks off a new chapter' By Investing.com
Investing.com· 18 hours agoDespite missing Q1 estimates, NVAX stock rose sharply after the company announced it has secured a...
French, US Drug Firms Team Up For Covid-flu Shot
International Business Times· 16 hours agoUnder a licensing deal worth up to $1.2 billion, the companies will co-commercialise Novavax's Covid-19 vaccine worldwide ...